| ProductNum | picture | CAS No. | Name and description | Size | Formula | Quick order |
|---|---|---|---|---|---|---|
| C600002986 |
|
22532-62-3 |
4-Bromo-2-hydroxybenzaldehyde - 98% |
0 | C7 H5 Br O2 | |
| C600002984 |
|
216503-57-0 |
Alemtuzumab - 98% |
0 | — | |
| C600002983 |
|
13749-61-6 |
N-ISOPROPYLMETHACRYLAMIDE - 98% |
0 | C7 H13 N O | |
| C600002982 |
|
1829-34-1 |
3-Bromo-2-hydroxybenzaldehyde - 98% |
0 | C7 H5 Br O2 | |
| C600002980 |
|
2188-18-3 |
N-Boc-N'-nitro-L-arginine - 98% |
0 | C11H21N5O6 | |
| C600002978 |
|
531-91-9 |
N,N'-Diphenylbenzidine - 98% |
0 | C24 H20 N2 | |
| C600002977 |
|
29753-26-2 |
N-(4-AMINOPHENYL)MALEIMIDE - 98% |
0 | C10 H8 N2 O2 | |
| C600002975 |
|
2075-45-8 |
4-Bromopyrazole - 98% |
0 | C3 H3 Br N2 | |
| C600002974 |
|
2135871-21-3 |
phenyl (R)-(5-(2-(2,5-difluorophenyl)pyrrolidin-1-yl)pyrazolo[1,5-a]pyrimidin-3-yl)carbamate - 98% |
0 | C23H19F2N5O2 | |
| C600002973 |
|
339177-26-3 |
Panitumumab - 98% |
0 | — | |
| C600002971 |
|
1714-29-0 |
1-Bromopyrene - 98% |
0 | C16 H9 Br | |
| C600002969 |
|
17609-80-2 |
4-Amino-3-chlorophenol - 98% |
0 | C6 H6 Cl N O | |
| C600002968 |
|
300-57-2 |
Allylbenzene - 98% |
0 | C9 H10 | |
| C600002967 |
|
2941-58-4 |
2-Bromo-6-methoxybenzothiazole - 98% |
0 | C8 H6 Br N O S | |
| C600002966 |
|
1208319-26-9 |
Oclacitinib - 98% |
0 | C15 H23 N5 O2 S | |
| C600002963 |
|
120-74-1 |
5-Norbornene-2-carboxylic acid - 98% |
0 | C8 H10 O2 | |
| C600002962 |
|
105728-90-3 |
2-FLUORO-5-METHOXYBENZALDEHYDE - 98% |
0 | C8 H7 F O2 | |
| C600002961 |
|
1443623-92-4 |
5-(2,5-difluorophenyl)-3,4-dihydro-2H-pyrrole - 98% |
0 | C10H9F2N | |
| C600002960 |
|
2746-19-2 |
(3aR,4R,7S,7aS)-rel-3a,4,7,7a-Tetrahydro-4,7-methanoisobenzofuran-1,3-dione - 98% |
0 | C9 H8 O3 | |
| C600002959 |
|
12136-58-2 |
LITHIUM SULFIDE - 98% |
0 | Li2 S | |
